Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
[Assessment of the pain patients with the multiple sclerosis after applying the physiotherapy treatment].
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Circulating innate lymphoid cells are unchanged in response to DAC HYP therapy.
Multiple sclerosis: association with HL-A3.
Extavia Prescribing Information
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence.
Bioengineered cell culture systems of central nervous system injury and disease.
Comparative effectiveness of early Natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis.
Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9.
Genentech and Biogen Idec announce top-line results from a Phase II/III clinical trial of Rituxan in primary-progressive multiple sclerosis
Receptos to deliver scientific presentation at Digestive Disease Week 2012 about the therapeutic role of RPC1063 in inflammatory bowel disease
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
Multiple sclerosis: A lifestyle disease?
Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
DNA strand breakage by peroxidase-activated mitoxantrone.
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.
Episode 3 with Drs. Daren Austin and Susan Van Meter on the MIRROR trial of ofatumumab
8th International Congress on Autoimmunity

Pages